Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Cost of Revenue (2024 - 2025)

Historic Cost of Revenue for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $11.1 million.

  • Kestra Medical Technologies' Cost of Revenue rose 2546.17% to $11.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $39.8 million, marking a year-over-year increase of 1876.12%. This contributed to the annual value of $35.6 million for FY2025, which is 2969.91% up from last year.
  • Per Kestra Medical Technologies' latest filing, its Cost of Revenue stood at $11.1 million for Q4 2025, which was up 2546.17% from $10.5 million recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year Cost of Revenue high stood at $11.1 million for Q4 2025, and its period low was $7.4 million during Q1 2024.